0
Is olaparib the only PARP inhibitor that has been approved?
- 1 people answered
0 Vote
1 Contributor
1988 Views 
0 Saved
0 Vote 1 Contributor1988 Views 0 SavedYou might also be interested in
Direct breastfeeding could cut the chance of breast cancer by up to one fifth. It’s actually a “powerful strategy” to reduce the risk of cancer for you, especially the most aggressive types of disease. Scientists believe the high hormone levels required for lactation appears to affect cell growth, p....
HER2 is a gene that creates HER2 proteins or receptors. These receptors help control growth and repair of breast cells. An overexpression of HER2 protein causes out-of-control reproduction of breast cells. HER2-positive breast cancers are known to be more aggressive than HER2-negative breast canc....
While you can’t change some breast cancer risk factors – family history and aging, for example – there are others that you can control. Here are 5 ways to help protect your breast health: Watch your weight as being overweight or obese increases breast cancer risk. This is especially true after....
Rahul Sharma
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy. For the treatment of adult patients with suspected deleterious germline BRCA-mutated advanced ovarian cancer which has been treated with 3 or more prior lines of chemotherapy. Patients should be selected for therapy based on an FDA-approved companion diagnostic for LYNPARZA. Poly (ADP-ribose) Polymerase, or PARP, enzymes mediate DNA repair by transferring ADP-ribose units to preexisting ADP-ribose chains on proteins and to proteins. This ADP–ribosylation process recruits DNA repair enzymes, thereby maintaining genomic integrity. Inhibiting this process can lead to the accumulation of DNA damage and, ultimately, cell death.